Literature DB >> 6682629

Scalp abscess: a benign and infrequent complication of fetal monitoring.

L Cordero, C W Anderson, F P Zuspan.   

Abstract

Scalp abscess is an infrequent and usually benign complication of the implantation of fetal heart rate electrodes that becomes noticeable from 2 to 10 days after birth. The lesions are usually single and localized. Most exudates will produce aerobic and/or anaerobic bacteria similar to the cervical flora of the late trimester of pregnancy. Scalp abscesses are more likely to occur subsequent to prolonged rupture of the membranes and an extended period of fetal heart rate monitoring. Local treatment may be adequate in most cases, but parenteral antibiotic therapy may be needed in others. Since herpes simplex virus infection has been reported to start as vesicles around the site of electrode implantation, careful attention to the maternal history must be given. The parents of infants who undergo internal fetal heart rate monitoring should be given careful and concise follow-up instructions when the infant is discharged from the hospital. It is apparent after a decade of experience that the benefits of electronic fetal heart rate monitoring, even when invasive, far outweigh the risks of this still infrequent complication.

Entities:  

Mesh:

Year:  1983        PMID: 6682629     DOI: 10.1016/0002-9378(83)91039-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Neonatal complications associated with use of fetal scalp electrode: a retrospective study.

Authors:  T Kawakita; U M Reddy; H J Landy; S N Iqbal; C-C Huang; K L Grantz
Journal:  BJOG       Date:  2015-12-08       Impact factor: 6.531

2.  Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study.

Authors:  Carol Elaine Adair; Laura Kowalsky; Harvey Quon; Doreen Ma; Jayson Stoffman; Allison McGeer; Sheila Robertson; Melissa Mucenski; H Dele Davies
Journal:  CMAJ       Date:  2003-08-05       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.